These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29270024)

  • 21. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer.
    Sakamoto K; Imai K; Higashi T; Taki K; Nakagawa S; Okabe H; Nitta H; Hayashi H; Chikamoto A; Ishiko T; Beppu T; Baba H
    Cancer Sci; 2015 Sep; 106(9):1153-62. PubMed ID: 26132727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
    Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
    Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma.
    Wu SY; Yu MX; Li XG; Xu SF; Shen J; Sun Z; Zhou X; Chen XZ; Tu JC
    Asian Pac J Cancer Prev; 2014; 15(7):3299-304. PubMed ID: 24815486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ring finger protein 43 expression is associated with genetic alteration status and poor prognosis among patients with intrahepatic cholangiocarcinoma.
    Talabnin C; Janthavon P; Thongsom S; Suginta W; Talabnin K; Wongkham S
    Hum Pathol; 2016 Jun; 52():47-54. PubMed ID: 26980022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High level of CD73 predicts poor prognosis of intrahepatic cholangiocarcinoma.
    Xu YP; Zhou YQ; Zhao YJ; Zhao Y; Wang F; Huang XY; Guo CY
    J Cancer; 2021; 12(15):4655-4660. PubMed ID: 34149929
    [No Abstract]   [Full Text] [Related]  

  • 27. Loss of UHRF2 expression is associated with human neoplasia, promoter hypermethylation, decreased 5-hydroxymethylcytosine, and high proliferative activity.
    Lu H; Bhoopatiraju S; Wang H; Schmitz NP; Wang X; Freeman MJ; Forster CL; Verneris MR; Linden MA; Hallstrom TC
    Oncotarget; 2016 Nov; 7(46):76047-76061. PubMed ID: 27738314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylation of UHRF2 affects malignant phenotypes of HCC and HBV replication by blocking DHX9 ubiquitylation.
    Wu K; Zhang Y; Liu Y; Li Q; Chen Y; Chen J; Duan C
    Cell Death Discov; 2023 Jan; 9(1):27. PubMed ID: 36690646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression.
    Zu C; Liu S; Cao W; Liu Z; Qiang H; Li Y; Cheng C; Ji L; Li J; Li J
    Oncotarget; 2017 May; 8(21):34698-34708. PubMed ID: 28423728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and prognostic significance of mortalin, Bcl-2 and Bax in intrahepatic cholangiocarcinoma.
    Kang Q; Zou H; Yang X; Cai JB; Liu LX; Xie N; Wang LM; Li YH; Zhang XW
    Oncol Lett; 2018 Feb; 15(2):2161-2168. PubMed ID: 29434920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated expression of G
    Cao XY; Ji HJ; Zhou YJ; Lu XF; Shen JY; Wu ZR; Bu H; Shi YJ
    Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):638-644. PubMed ID: 29291784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.
    Wu J; Yang B; Zhang Y; Feng X; He B; Xie H; Zhou L; Wu J; Zheng S
    Int J Biol Sci; 2019; 15(8):1591-1599. PubMed ID: 31360102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UHRF2, another E3 ubiquitin ligase for p53.
    Bai L; Wang X; Jin F; Yang Y; Qian G; Duan C
    Biochem Biophys Res Commun; 2012 Sep; 425(4):908-11. PubMed ID: 22902639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.
    Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Nardilysin, a Surrogate Marker for Epithelial-Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection.
    Yoh T; Hatano E; Kasai Y; Fuji H; Nishi K; Toriguchi K; Sueoka H; Ohno M; Seo S; Iwaisako K; Taura K; Yamaguchi R; Kurokawa M; Fujimoto J; Kimura T; Uemoto S; Nishi E
    Clin Cancer Res; 2019 Jan; 25(2):619-628. PubMed ID: 30352908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study.
    Bi C; Liu M; Rong W; Wu F; Zhang Y; Lin S; Liu Y; Wu J; Wang L
    BMC Cancer; 2019 Mar; 19(1):213. PubMed ID: 30849962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of LARP1 and E-cadherin expression with prognosis of intrahepatic cholangiocarcinoma.
    Jiang F; Fang DB; Lin J; Chen Q; Zhu LX; Yu HZ
    Int J Clin Exp Pathol; 2018; 11(7):3559-3566. PubMed ID: 31949734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Nomogram Based on Histological Characteristics of Fibrotic Tumor Stroma in Patients Who Underwent Curative Resection for Intrahepatic Cholangiocarcinoma.
    Jing CY; Fu YP; Huang JL; Zhang MX; Yi Y; Gan W; Xu X; Shen HJ; Lin JJ; Zheng SS; Zhang J; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
    Oncologist; 2018 Dec; 23(12):1482-1493. PubMed ID: 30257891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UHRF1 is regulated by miR-124-3p and promotes cell proliferation in intrahepatic cholangiocarcinoma.
    Zhu M; Wei C; Lin J; Dong S; Gao D; Chen J; Zhao Y; Liu B
    J Cell Physiol; 2019 Nov; 234(11):19875-19885. PubMed ID: 30989656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenomedullin promotes intrahepatic cholangiocellular carcinoma metastasis and invasion by inducing epithelial-mesenchymal transition.
    Zhou C; Zheng Y; Li L; Zhai W; Li R; Liang Z; Zhao L
    Oncol Rep; 2015 Aug; 34(2):610-6. PubMed ID: 26043778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.